METHODS: Adult outpatients with DSM-IV-defined major depressive disorder and a __number__ -item Hamilton Rating Scale for Depression (HAM-D( __number__ )) total score __number__ were randomly assigned to receive placebo or desvenlafaxine ( __number__ or __number__ mg/day) after a __number__ - to __number__ -day single-blind placebo lead-in period in an __number__ -week, phase __number__ , fixed-dose trial.